Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Lymphoma 7Leukemia 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Renal Cell 5Unspecified Adult Solid Tumor, Protocol Specific 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myeloid, Acute 4Burkitt Lymphoma 4Kidney Neoplasms 3Waldenstrom Macroglobulinemia 2Stomach Neoplasms 2Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Multiple Myeloma 2Melanoma 2Lymphoma, T-Cell, Cutaneous 2Leukemia, Myelomonocytic, Chronic 2Hodgkin Disease 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Blast Crisis 2Anemia, Refractory 2

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 72apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × bryostatin 1 × Clear all
NCT00006389 2014-10-01

Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer

National Cancer Institute (NCI)

Phase 2 Completed
12 enrolled 7 charts
Gastrointestinal

Stomach Neoplasms

NCT00005599 2013-06-21

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡